Biologic therapy has revolutionized the treatment of IBD and improved patient outcomes drastically. Many of…
jwood@krftwrk.caDecember 13, 2016
ESMO 2016. LBA14_PR. FALCON: A phase III randomised trial of fulvestrant 500 mg vs. anastrozole…
jwood@krftwrk.caNovember 9, 2016
ESMO 2016. LBA8_PR. KEYNOTE-024: Pembrolizumab (pembro) vs platinum-based chemotherapy (chemo) as first-line therapy for advanced…
jwood@krftwrk.caNovember 9, 2016
ESMO 2016. Abstract 819P. Real world outcomes of patients with metastatic renal cell carcinoma (mRCC)…
jwood@krftwrk.caNovember 9, 2016
News in Lung Cancer ASCO 2015. Abstract 9001. Epidermal growth factor receptor (EGFR) genotyping of…
jwood@krftwrk.caJune 29, 2016
News in Prostate Cancer ASCO 2016. Abstract 5059. Effects of abiraterone (ABI) and enzalutamide (ENZA)…
jwood@krftwrk.caJune 29, 2016
Colorectal Cancer ASCO 2016. Abstract 3504. Impact of primary (1º) tumor location on overall survival…
jwood@krftwrk.caJune 29, 2016
Head and Neck Cancer ASCO 2016. Abstract 6008. BERIL-1: A phase II, placebo-controlled study of…
jwood@krftwrk.caJune 29, 2016
Metastatic Breast Cancer ASCO 2016. Abstract 525. Prevention of everolimus/exemestane (EVE/EXE) stomatitis in postmenopausal (PM)…
jwood@krftwrk.caJune 29, 2016
